IN THE UNITED STATES DISTRICT COURT

KELLYN CLAY,
  Plaintiff,

v.

UNITED STATES OF AMERICA,
by and through its agencies including but not limited to
the Central Intelligence Agency (CIA), Department of Defense (DoD),
and Department of Justice (DOJ),

and

WILLIAM ALTON CLAY,
individually and in his capacity as executor of the Estate of Eugenia Clay Head,

and

PALANTIR TECHNOLOGIES INC.,
a private defense contractor headquartered in Denver, Colorado,

and

JOHN DOE CONTRACTING AGENCIES AND AFFILIATES,
whose names and identities are presently unknown,

and

AMAZON.COM, INC.,
a multinational e-commerce corporation headquartered in Seattle, Washington,

and

REV.COM, INC.,
a transcription and captioning services company headquartered in Austin, Texas,

and

PAPERBOY MARKETING,
a flyer distribution company operating in the Twin Cities under successive ownership during the period of Plaintiff’s employment,

and

ELLIE FAMILY SERVICES, n/k/a ELLIE MENTAL HEALTH, a private mental health services corporation headquartered in Mendota Heights, Minnesota,
  Defendants.

⸻ 

PLAINTIFF’S COMBINED SET OF DISCOVERY REQUESTS TO DEFENDANT PALANTIR TECHNOLOGIES INC.

Definitions
	1.	“Merle Norman” refers to Merle Norman Cosmetics, Inc., including all affiliates, franchises, employees, and contractors.
	2.	“Implant array” refers to any neural, cranial, auditory, trigeminal, or related hardware or software system associated with Plaintiff.
	3.	“Event” refers specifically to the piercing and cosmetic consultation experienced by Plaintiff at a Merle Norman location in or around June 2002.

⸻

INTERROGATORIES
  1.  Identify and describe in detail any records, programs, or activities maintained by Palantir Technologies, Inc., or its predecessor entities, involving:

a. The use of ear-piercing, earrings, or cosmetic procedures (including but not limited to makeup consultations) as vectors for the insertion, calibration, or enhancement of implant arrays;

b. Any files, retrospective analyses, or surveillance records specifically referencing Plaintiff’s ear-piercing and makeup consultation at Merle Norman in or around June 2002; and

c. Any contracts, communications, or collaborations between Palantir (or predecessor entities) and Merle Norman Cosmetics, Inc., or similar cosmetic retailers, concerning the use of cosmetic procedures for surveillance or implant-related purposes.

For each instance, state:
	•	The date(s);
	•	The program(s) or project(s) under which the activity was conducted;
	•	The Palantir personnel or predecessor entities involved;
	•	The purpose and intended outcome of the activity; and
	•	Whether Plaintiff’s data was collected, stored, or acted upon in connection with the Event.
   2.  Identify and describe in detail any programs, files, or activities maintained by Palantir Technologies, Inc., or its predecessor entities, involving the use of cosmetic accessories—including but not limited to hair elastics, hair clips, bobby pins, earrings, or other items worn on or around the head and ears—as vectors for the insertion, calibration, or enhancement of implant arrays.

For each such program or activity, state:
	•	The date(s) and duration;
	•	The accessory types involved;
	•	The personnel, contractors, or agencies participating;
	•	The purpose and intended effect of the accessory in relation to implant-array functioning; and
	•	Whether Plaintiff’s data was collected, stored, or acted upon in connection with such use.

⸻ 

REQUESTS FOR PRODUCTION
	1.	Produce all documents, communications, or files maintained by Palantir referencing Plaintiff’s ear-piercing and makeup consultation at Merle Norman in June 2002.
	2.	Produce all documents describing the use of earrings, cosmetic products, or topical agents as vectors for implant enhancement, calibration, or activation.
	3.	Produce all documents reflecting historical or retrospective modeling of Plaintiff’s medical, cosmetic, or consumer experiences, including implant-array alignment associated with the June 2002 Merle Norman event.
	4.	Produce all communications or reports referencing third-party partnerships (including but not limited to Merle Norman or similar cosmetic retailers) used to facilitate implant insertion, enhancement, or maintenance.
	5.	Produce all internal memoranda, training materials, or project notes describing the role of cosmetic procedures (piercing, makeup consultation, skin-contact products) in relation to surveillance or implant systems.
	6.	Produce all documents reflecting executive oversight, program sponsorship, or interagency coordination concerning cosmetic retail locations used as implant-array touchpoints.
	7.	Produce all documents describing or evidencing the targeting of Plaintiff as a minor for implant-related experimentation, enhancement, or data collection in or around June 2002.

⸻ 

REQUESTS FOR ADMISSION

  1.  Admit that Palantir Technologies, Inc., directly or indirectly, maintains files, records, or retrospective analyses referencing Plaintiff’s ear-piercing and cosmetic consultation at Merle Norman in or around June 2002, including in connection with the calibration or enhancement of implant arrays.
   2.  Admit that Palantir Technologies, Inc., directly or indirectly, has collected, maintained, or analyzed data concerning the use of cosmetic retail environments—including but not limited to ear-piercing services, makeup consultations, or skin-contact product trials—as sites for the insertion, calibration, or enhancement of implant arrays.
   3.  Admit that Palantir Technologies, Inc., directly or indirectly, has collected, maintained, or analyzed data concerning the use of cosmetic accessories—including but not limited to hair elastics, hair clips, bobby pins, earrings, or similar items worn on or around the head and ears—as vectors for the insertion, calibration, or enhancement of implant arrays.

